Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says
Source link
Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says
Source link
Finizer is an educational platform and not a SEBI-registered investment advisory service. All content is for learning purposes only. Financial markets involve risk, and education is the foundation of responsible participation.